Cardiac resynchronization therapy defibrillator: de novo implant in a COVID-19 patient by an echo-guided axillary venous approach

The COVID-19 pandemic has seriously revolutionized the management of patients who need an implanted cardiac implantable electronic device. We report, for the first time, a successful cardiac resynchronization therapy defibrillator implantation procedure in an 82-year-old man affected by COVID-19, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Agea, Aldo, Bellino, Maria C, Gianfrancesco, Domenico, Palma, Francesco, Carpagnano, Giuseppe A, Torraco, Rita MR, Marino, Maria M, Persichella, Paola, Zingaro, Sebastiano, Siena, Fabio, Di Tullio, Roberto, Deluca, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245564/
https://www.ncbi.nlm.nih.gov/pubmed/35735185
http://dx.doi.org/10.2217/fca-2021-0055
Descripción
Sumario:The COVID-19 pandemic has seriously revolutionized the management of patients who need an implanted cardiac implantable electronic device. We report, for the first time, a successful cardiac resynchronization therapy defibrillator implantation procedure in an 82-year-old man affected by COVID-19, recent myocardial infarction, second-degree 2:1 atrioventricular block and left bundle branch block.

Ejemplares similares